Handelsbanken Fonder AB Boosts Holdings in Astera Labs, Inc. $ALAB

Handelsbanken Fonder AB grew its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 11.3% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 44,500 shares of the company’s stock after acquiring an additional 4,500 shares during the quarter. Handelsbanken Fonder AB’s holdings in Astera Labs were worth $21,494,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of ALAB. Atreides Management LP increased its position in Astera Labs by 108.9% during the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares during the last quarter. Amundi raised its stake in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership acquired a new position in shares of Astera Labs in the 4th quarter valued at $148,980,000. Goldman Sachs Group Inc. boosted its holdings in shares of Astera Labs by 189.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after purchasing an additional 858,693 shares during the last quarter. Finally, State Street Corp grew its stake in shares of Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after buying an additional 760,358 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ALAB has been the subject of a number of research analyst reports. Evercore restated an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Royal Bank Of Canada boosted their price target on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Citigroup restated a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Roth Capital restated a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Finally, Susquehanna lifted their price objective on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. Thirteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $325.25.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: AI infrastructure opportunity: Astera’s Scorpio high-radix fabric switch could become its largest revenue source, increasing average selling prices and enabling cross-selling across its connectivity portfolio. An analyst rates ALAB a Buy with a $370 price target, citing the company’s interoperability, software controls and positioning across different accelerator platforms. Astera Labs: The AI Fabric Inflection Is Arriving Faster Than Expected
• Positive Sentiment: Connectivity demand remains strong: Astera’s record growth, PCIe 6 capabilities and expanding product lineup may help it gain share against Marvell and Credo, supporting continued revenue and earnings momentum. ALAB Benefits From PCIe Demand: Can It Stay Ahead of Its Competitors?
• Positive Sentiment: Profit forecasts were sharply raised: Northland Securities lifted its FY2026 EPS estimate to $2.75 from $1.82 and its FY2027 estimate to $5.43 from $2.26. Quarterly estimates were also increased substantially, indicating expectations for faster operating growth.
• Positive Sentiment: AMD ecosystem tailwind: AMD’s Helios rack-scale AI systems are expected to ramp, potentially benefiting Astera Labs as an infrastructure and connectivity supplier alongside other ecosystem partners. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
• Neutral Sentiment: Recent coverage compares ALAB’s performance with the broader technology sector and ASE Technology, but provides no specific new catalyst or downgrade.
• Negative Sentiment: Northland maintained a “Market Perform” rating despite raising estimates. ALAB also trades at a very demanding valuation, with a price-to-earnings ratio above 200 and a share price below its 50-day average, leaving the stock sensitive to any slowdown in AI spending or execution.

Insider Activity at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 111,214 shares of the business’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $216.89, for a total transaction of $24,121,204.46. Following the transaction, the chief executive officer owned 3,817,969 shares in the company, valued at $828,079,296.41. The trade was a 2.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the sale, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. The trade was a 11.67% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,256,894 shares of company stock valued at $362,763,135 over the last 90 days. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Trading Up 2.2%

Shares of ALAB stock opened at $318.80 on Thursday. The company’s fifty day simple moving average is $358.62 and its 200-day simple moving average is $238.55. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The company has a market cap of $55.31 billion, a PE ratio of 157.82 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the previous year, the business posted $0.44 EPS. The business’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.